天美传媒

Rachel Hess, MD, MS is a Professor of Population Health Sciences and Internal Medicine and the founding Chief of the Division of Health System Innovation and Research (HSIR) program at the University of Utah Schools of the Health Sciences. As a clinician and Health Services Researcher, Dr. Hess brings a unique perspective of translating research into clinical and policy practice. She is the co-principal investigator of one of the original 11 PCORnet Clinical Data Research Networks, PaTH and serves as the co-Director of the Utah CCTS. Dr. Hess’s research aims to improve patient-centered outcomes in clinical care. In service of this mission, she seeks to understand the determinants of quality of life, including sexual function, and how the health-related quality of life affects health and cost outcomes. She has conducted cohort studies in midlife women to examine the impact of menopause on health-related quality of life, including sexual functioning. She is currently following a cohort of adults over 50 to characterize the roles of intrapersonal resources, interpersonal relationships, and individual lifestyle in shaping the quality of life across transitions; and the health and healthcare-cost outcomes of quality of life. Dr. Hess’s implementation work uses health information technology to engage patients in their care. She has examined the impact of providing patients with guideline-based feedback regarding their health behaviors and health-related quality of life on patient activation and behavior change. Dr. Hess has overseen the development and successful implementation of multiple technology-based programs in primary care. As the director of HSIR, she brings together individuals from across the University of Utah to develop, test, and implement novel approaches that improve health outcomes for the population. Dr. Hess completed her undergraduate work in mathematics at Washington University, received her medical degree from the University of New Mexico, completed her residency training at Temple University, and completed her general internal medicine and women’s health fellowships at the University of Pittsburgh.

Hannah holds a BSc (Hons) in Sport and Exercise Science from the University of Bedfordshire (2013). Hannah subsequently completed a PhD at Liverpool John Moores University under the Supervision of Professor Adam Sharples and Professor Claire Stewart where she investigated the effectiveness of the polyphenol resveratrol in preventing muscle atrophy within an in vitro model of caloric restriction. On completion of her PhD in 2017, Hannah undertook a post-doctoral position at the University of Oxford, working under the leadership of Professor Dame Kay Davies. This work was in collaboration with Summit therapeutics with the aim to elucidate novel regulatory pathways understanding the mechanistic action of potential drug candidates designed to modulate utrophin in the hopes of mitigating the pathology in Duchenne muscular dystrophy. Hannah then moved to Kings College London in 2019 where she worked with Dr Julien Ochala utilising single muscle fibre techniques to examine physiological dysfunction and associated causes of congenital myopathies. Hannah took up a role as Lecturer in the area of molecular and cellular physiology in the School of Sport, Exercise and Health Sciences in 2022.